tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

BICO’s Biosero Unveils GoSimple Workcell in Sartorius and BD Lab Automation Tie-Up

Story Highlights
  • BICO’s Biosero is launching GoSimple, a standardized, automation-ready workcell that integrates with Green Button Go software to cut manual lab work and accelerate deployment of high-throughput workflows.
  • Initial GoSimple configurations pair with Sartorius Octet BLI and BD flow cytometry systems, with both partners promoting the solution to drive broader adoption and bolster BICO’s lab automation market presence.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
BICO’s Biosero Unveils GoSimple Workcell in Sartorius and BD Lab Automation Tie-Up

Claim 50% Off TipRanks Premium

BICO Group AB Class B ( (SE:BICO) ) just unveiled an announcement.

BICO’s subsidiary Biosero is launching GoSimple, a standardized, automation-ready benchtop workcell, at SLAS 2026 in Boston, targeting high-throughput applications such as quantification, analyte and clone screening, and cell line development. Integrated with Biosero’s Green Button Go Scheduler, the pre-configured system is designed to accelerate deployment of lab automation, cut manual handling and errors, and extend operating hours without increasing headcount. The first GoSimple configurations incorporate selected instruments from Sartorius and Becton, Dickinson and Company, with both partners set to promote the solution alongside their platforms—Sartorius around its Octet BLI systems and BD around its FACSLyric and FACSymphony analyzers—supporting broader market adoption. By positioning GoSimple as a preferred, ready-to-run automation solution across multiple instrument ecosystems, BICO is strengthening its footprint in lab automation and offering pharmaceutical, biotech and research customers a more scalable, reproducible, and cost-efficient path to automated data generation.

The most recent analyst rating on (SE:BICO) stock is a Hold with a SEK18.00 price target. To see the full list of analyst forecasts on BICO Group AB Class B stock, see the SE:BICO Stock Forecast page.

More about BICO Group AB Class B

BICO Group AB is a Sweden-listed lab automation partner serving pharmaceutical and biotech companies through its Lab Automation and Life Science Solutions divisions. With more than 48,000 instruments installed in over 65 countries and a customer base that includes the world’s 20 largest drug makers and over 3,500 laboratories, BICO provides hardware, software and integrated workflows aimed at enabling and automating the life science laboratory of the future. Its subsidiary Biosero develops science-centric software and automation platforms, including the Green Button Go suite, to coordinate complex workflows and boost productivity in life science, biotechnology, pharmaceutical and diagnostic research.

Average Trading Volume: 205,749

Technical Sentiment Signal: Sell

Current Market Cap: SEK1.26B

Find detailed analytics on BICO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1